United States v. Derrick Herring
641 F. App'x 451
6th Cir.2016Background
- Defendant Derrick Herring (alias “George”) was arrested after a controlled buy; Gibson (cooperating witness) had reported trafficking and regular purchases from Herring. A jury convicted Herring of conspiracy to distribute oxycodone; district court sentenced him to 168 months and 4 years supervised release.
- Gibson testified that for 2–3 months he bought large quantities (200–300 pills, sometimes more) from Herring once or twice weekly; Gibson sometimes received pills on credit (“fronting”) and once held about $30,000 for Herring.
- Herring supplied Gibson a money counter and gave Gibson two lockboxes (unused) intended for a dual-key drug-sale scheme; other witnesses (Oiler, Clemons) also testified to purchases from Herring.
- At trial the prosecutor’s closing argued that Herring was a source of supply fueling regional oxycodone abuse and urged targeting suppliers to “cut off the head of the snake.” Herring did not object to the closing remarks at trial.
- At sentencing the court attributed 8,000 thirty-milligram oxycodone pills to Herring and applied a two-level leadership enhancement under U.S.S.G. § 3B1.1.
Issues
| Issue | Plaintiff's Argument | Defendant's Argument | Held |
|---|---|---|---|
| Sufficiency of evidence for conspiracy | Govt: Evidence of repeated large sales, fronting, money counter, lockbox scheme shows conspiracy | Herring: Transactions were independent buyer-seller sales, not a conspiracy | Affirmed — de novo review: evidence permitted a rational juror to find a conspiracy |
| Prosecutor’s improper appeal to community conscience | Govt: closing remarks were permissible advocacy about social harms | Herring: Prosecutor urged jurors to convict to solve community drug problem (impermissible) | Remarks improper but not plain error given limited scope and overwhelming evidence; no new trial |
| Drug-quantity attribution at sentencing | Govt: 8,000 pills supported by trial/PSR testimony and conservative calculations | Herring: PSR and government misstated trial testimony; court should have used lower estimate | Affirmed — district court’s 8,000-pill approximation supported by competent evidence and not clearly erroneous |
| Leadership enhancement under U.S.S.G. § 3B1.1 | Govt: Herring exercised authority over Gibson (money counter, $30,000 deposit, lockbox plan) | Herring: Mere buyer/seller activity does not justify enhancement | Affirmed — enhancement appropriate; behavior exceeded ordinary buyer/seller role (plain-error review) |
Key Cases Cited
- United States v. Washington, 715 F.3d 975 (6th Cir.) (standard for de novo review of sufficiency)
- United States v. Anderson, 89 F.3d 1306 (6th Cir.) (buyer–seller relationship alone insufficient for conspiracy)
- United States v. Martinez, 430 F.3d 317 (6th Cir.) (repeated large purchases can support conspiracy inference)
- United States v. Lopez-Medina, 461 F.3d 724 (6th Cir.) (fronting drugs can show more than buyer–seller)
- United States v. Solivan, 937 F.2d 1146 (6th Cir.) (prosecutor may not urge jury to solve social problems by convicting defendant)
- United States v. Barnett, 398 F.3d 516 (6th Cir.) (factors for assessing flagrancy/plain error in prosecutorial misconduct)
- United States v. Henley, 360 F.3d 509 (6th Cir.) (clear-error review of drug-quantity findings; importance of evidentiary support)
- United States v. Hernandez, 227 F.3d 686 (6th Cir.) (approximations of drug quantity must be supported and may err on side of caution)
- United States v. Jeross, 521 F.3d 562 (6th Cir.) (coconspirator testimony can support drug-quantity attribution)
- United States v. Vasquez, 560 F.3d 461 (6th Cir.) (factors supporting § 3B1.1 leadership enhancement)